| Code | Description | Claims | Beneficiaries | Total Paid |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,427 |
4,521 |
$256K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
4,462 |
3,639 |
$214K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
7,306 |
5,970 |
$209K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,463 |
5,322 |
$199K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
7,149 |
6,146 |
$63K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
4,739 |
3,977 |
$55K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
1,070 |
957 |
$40K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,755 |
2,183 |
$29K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
173 |
159 |
$14K |
| 99215 |
Prolong outpt/office vis |
98 |
88 |
$7K |
| 87807 |
|
321 |
223 |
$2K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,418 |
1,912 |
$897.68 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
30 |
24 |
$529.51 |
| 81003 |
|
318 |
266 |
$429.59 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
2,590 |
2,110 |
$230.75 |
| 36415 |
Collection of venous blood by venipuncture |
100 |
83 |
$118.37 |
| 71045 |
Radiologic examination, chest; single view |
15 |
12 |
$98.34 |
| 86308 |
|
16 |
16 |
$68.04 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
65 |
45 |
$0.62 |